Cyberattacks cost the pharmaceutical industry an average of $5.06 million per breach – more than healthcare, energy, or finance. Ransomware attacks surged 30% in 2025, and nearly 20% of sensitive files in healthcare organizations are accessible to every employee.
Pharma is a prime target due to valuable IP, clinical trial data, and proprietary R&D. Third-party software, supply chain weaknesses, and interconnected systems remain key entry points — and even brief disruptions can halt production, cause drug shortages, or directly compromise patient safety.
Siemens Digital Industries addresses these risks with a field-proven cybersecurity concept based on IEC 62443 and a Defense-in-Depth approach – covering secure remote access, multi-vendor environments, IP protection, and compliance with NIS2 and the Cyber Resilience Act (CRA).





